Bilirubin Total Gen3 5795648190Recalls & reported problems
Roche Diagnostics GmbH · Class 2
All models of Bilirubin Total Gen3 (3)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04015630928910), received between Apr 25, 2019 and Apr 25, 2019 — classified as 1 malfunction.
The most frequently reported specific device problem is “Non Reproducible Results” (1 report).
2 other recalls cover devices cleared under the same FDA submission (K131544); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Non Reproducible Results1
Patient problems
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 25, 2019Non Reproducible Results; Non Reproducible Results
THIS REPORT SUMMARIZES <NOE>1</NOE> MALFUNCTION EVENT. NON-REPRODUCIBLE RESULTS WERE GENERATED BY THE COBAS C 111. THE EVENT INVOLVED A TOTAL OF 2 PATIENTS TESTED FOR BILT3 BILIRUBIN TOTAL GEN.3.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8549733 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K131544. One submission often covers many models, so check the product and lot details in each record.
- Z-0153-2020 · Sep 11, 2019 · TerminatedCobas c Bilirubin Total Gen.3 Catalog Number: 05795419190 - Product Usage: In vitro test for the quantitative determination of the total bilirubin in serum and plasma of adults an
- Z-1145-2019 · Dec 17, 2018 · TerminatedBilirubin Total Gen.3, Cat. Nos. 05795397190, 05795419190, 05795320160, 05795338160, 05795346160 ***added as of 5/10/19***05795397190, 05795648190 Product Usage: In vitro te
Other DIAZO COLORIMETRY, BILIRUBIN devices
- Dimension® Flex® reagent cartridge TBI 10444957Siemens Healthcare Diagnostics Inc. · DIAZO COLORIMETRY, BILIRUBIN2 recalls4 reports
- Dimension Vista® Flex® reagent cartridge TBIL 10445146Siemens Healthcare Diagnostics Inc. · DIAZO COLORIMETRY, BILIRUBIN1 recall7 reports
- VITROS 8383051Ortho-Clinical Diagnostics, Inc. · DIAZO COLORIMETRY, BILIRUBIN1 recall5 reports
- VITROS 1612365Ortho-Clinical Diagnostics, Inc. · DIAZO COLORIMETRY, BILIRUBIN1 recall1 report
- ARCHITECT 6L45-21Abbott Laboratories · DIAZO COLORIMETRY, BILIRUBIN46 reports
- ARCHITECT 6L45-22Abbott GmbH · DIAZO COLORIMETRY, BILIRUBIN30 reports
- ARCHITECT 6L45-41Abbott Laboratories · DIAZO COLORIMETRY, BILIRUBIN18 reports
- Bilirubin Direct Gen.2 08056951190Roche Diagnostics GmbH · DIAZO COLORIMETRY, BILIRUBIN17 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page